Collagenase injection - MatrizymeAlternative Names: MZ-004
Latest Information Update: 08 Mar 2016
At a glance
- Originator Matrizyme
- Class Cicatrizants; Collagenases
- Mechanism of Action Collagen inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Arterial occlusive disorders
Most Recent Events
- 01 Nov 2009 Phase-I clinical trials in Arterial occlusive disorders in Canada (Intracoronary)